High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion

被引:14
|
作者
Zhao, Jingzhu [1 ]
Yun, Xinwei [1 ]
Ruan, Xianhui [1 ]
Chi, Jiadong [1 ]
Yu, Yang [1 ]
Li, Yigong [1 ]
Zheng, Xiangqian [1 ]
Gao, Ming [1 ]
机构
[1] Tianjin Med Univ, Dept Thyroid & Neck Tumor, Key Lab Canc Prevent & Therapy,Canc Inst & Hosp, Natl Clin Res Ctr Canc,Tianjins Clin Res Ctr Canc, Huanhuxi Rd, Tianjin 300060, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2019年 / 12卷
关键词
NUCB2; papillary thyroid cancer; proliferation; invasion; PROGNOSTIC-FACTOR; NUCLEOBINDIN; 2; MOLECULAR-CLONING; BINDING PROTEIN; CARCINOMA; IDENTIFICATION; STATISTICS; MORTALITY; NEFA;
D O I
10.2147/OTT.S184560
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: NUCB2, a novel multifunctional protein containing several functional domains, was newly found to play important roles in many cancers, but its role in papillary thyroid cancer (PTC) is not well investigated. Therefore, our study was performed to explore the functions of NUCB2 in PTC. Methods: NUCB2 protein level was analyzed by immunohistochemistry. Data analyses were made by performing chi-squared test. Quantitative reverse-transcription PCR, Western blot colony formation, MTT, and transwell invasion assays were performed to test the expression levels and functions of NUCB2 in PTC. Results: In PTC tissues, NUCB2 protein expression level was positively correlated with extrathyroidal extension, TNM stage, and tumor size of PTC patients. In vitro experiments demonstrated that knockdown of NUCB2 using specific shRNA for NUCB2 significantly impaired cell proliferation and invasion of PTC cell lines. In vivo, silencing ofNUCB2 inhibited the growth of tumors in mice. Conclusion: These results suggested a novel function ofNUCB2 in the process of proliferation and invasion in PTC. NUCB2 may be considered a potent prognostic factor in PTC.
引用
收藏
页码:1309 / 1318
页数:10
相关论文
共 50 条
  • [41] MiR-23a promotes cell proliferation and invasion in papillary thyroid carcinoma by targeting PTEN
    Wen, Qiang
    Zhang, Daqi
    Wang, Ting
    Wang, Tongtong
    Zhao, Min
    Xie, Qian
    Fu, Yantao
    Ma, Qinglie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 2366 - 2373
  • [42] HMGA2 Overexpression in Papillary Thyroid Cancer Promotes Thyroid Cell Dedifferentiation and Invasion, and These Effects Are Counteracted by Suramin
    Van Branteghem, Cindy
    Henry, Nicolas
    Craciun, Ligia
    Maenhaut, Carine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)
  • [43] TRPC5 expression promotes the proliferation and invasion of papillary thyroid carcinoma through the HIF-1α/Twist pathway
    Yang, Jing
    Cheng, Yue
    Nie, Yan
    Tian, Bole
    Huang, Jing
    Gong, Rixiang
    Li, Zhihui
    Zhu, Jingqiang
    Gong, Yanping
    TRANSLATIONAL ONCOLOGY, 2024, 39
  • [44] NUCB2/nesfatin-1: Expression and functions in the regulation of emotion and stress
    Wei, Yanyan
    Li, Jiangbo
    Wang, Huiling
    Wang, Gaohua
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 81 : 221 - 227
  • [45] Overexpression of TROP2 promotes proliferation and invasion of ovarian cancer cells
    Wu, Bin
    Yu, Chunli
    Zhou, Bin
    Huang, Tingting
    Gao, Lei
    Liu, Tao
    Yang, Xingsheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (03) : 1947 - 1952
  • [46] NUCB-2/Nesfatin-1 promotes the proliferation of nasopharyngeal carcinoma cells
    Liang, Yunlai
    Ma, Yating
    Wang, Kun
    Xiang, Manglin
    Yi, Bin
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [47] NUCB-2/Nesfatin-1 promotes the proliferation of nasopharyngeal carcinoma cells
    Yunlai Liang
    Yating Ma
    Kun Wang
    Manglin Xiang
    Bin Yi
    Cancer Cell International, 23
  • [48] CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
    Han, Yong
    Xu, Shujian
    Cheng, Kai
    Diao, Caimei
    Liu, Song
    Zou, Weiwei
    Bi, Yueyang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [49] LncRNA CASC2 expression is down-regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway
    Zhou, Tao
    Zhong, Meijun
    Zhang, Shuyong
    Wang, Zhi
    Xie, Rong
    Xiong, Chengfeng
    Lv, Yunxia
    Chen, Wanzhi
    Yu, Jichun
    CANCER BIOMARKERS, 2018, 23 (02) : 185 - 191
  • [50] EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells
    Wang Xuqing
    Cui Lei
    Mao Zhengfa
    Dang Shengchun
    Fan Xin
    Qu Jianguo
    Zhang Jianxin
    TUMOR BIOLOGY, 2012, 33 (05) : 1419 - 1427